Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K. A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction. PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
Rauskolb C, Pan G, Reddy BV, Oh H, Irvine KD. Zyxin links fat signaling to the hippo pathway. PLoS Biol (2011) 9(6) e1000624
[
PubMed ID = 21666802
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
6 |
21 |
NM_132267.4 |
CG12109-RB (Caf1-180), mRNA |
0.62 |
3 |
4 |
14 |
42 |
NM_058003.3 |
CG5216-RA (Sir2), mRNA |
0.41 |
2 |
3 |
2 |
10 |
NM_166466.2 |
CG10082-RA, transcript variant A (CG10082), mRNA |
0.41 |
2 |
3 |
2 |
8 |
NM_137751.3 |
CG10082-RB, transcript variant B (CG10082), mRNA |
0.2 |
1 |
5 |
5 |
21 |
NM_080320.2 |
CG3653-RB, transcript variant B (kirre), mRNA |
0.2 |
1 |
5 |
5 |
21 |
NM_166958.1 |
CG3653-RA, transcript variant A (kirre), mRNA |
0.2 |
1 |
4 |
7 |
20 |
NM_130585.2 |
CG14810-RA (CG14810), mRNA |
0.2 |
1 |
3 |
4 |
7 |
NM_136202.4 |
CG31678-RA (CG31678), mRNA |
0.2 |
1 |
3 |
2 |
4 |
NM_139967.1 |
CG7037-RB, transcript variant B (Cbl), mRNA |
0 |
0 |
7 |
3 |
13 |
NM_139804.1 |
CG14821-RA (CG14821), mRNA |
0 |
0 |
6 |
9 |
14 |
NM_135388.2 |
CG9233-RA (fu2), mRNA |
0 |
0 |
6 |
3 |
17 |
NM_132280.3 |
CG10648-RA (CG10648), mRNA |
0 |
0 |
5 |
18 |
67 |
NM_132413.1 |
CG15295-RA (CG15295), mRNA |
0 |
0 |
5 |
16 |
45 |
NM_132457.1 |
CG11122-RA (CG11122), mRNA |
0 |
0 |
5 |
13 |
20 |
NM_137951.1 |
CG5357-RA (CG5357), mRNA |
0 |
0 |
5 |
8 |
50 |
NM_206628.1 |
CG32767-RB, transcript variant B (CG32767), mRNA |
0 |
0 |
5 |
8 |
50 |
NM_131975.3 |
CG32767-RA, transcript variant A (CG32767), mRNA |
0 |
0 |
5 |
3 |
17 |
NM_137047.2 |
CG6197-RA (CG6197), mRNA |
0 |
0 |
5 |
3 |
7 |
NM_080332.2 |
CG11427-RA (rb), mRNA |
0 |
0 |
4 |
23 |
46 |
NM_167309.1 |
CG32663-RA (CG32663), mRNA |
0 |
0 |
4 |
21 |
109 |
NM_001014737.1 |
CG7107-RG, transcript variant G (up), mRNA |
0 |
0 |
4 |
21 |
109 |
NM_080349.2 |
CG7107-RA, transcript variant A (up), mRNA |
0 |
0 |
4 |
21 |
109 |
NM_167375.1 |
CG7107-RB, transcript variant B (up), mRNA |
0 |
0 |
4 |
21 |
109 |
NM_001014738.1 |
CG7107-RF, transcript variant F (up), mRNA |
0 |
0 |
4 |
21 |
109 |
NM_167376.1 |
CG7107-RD, transcript variant D (up), mRNA |
0 |
0 |
4 |
20 |
106 |
NM_001014739.1 |
CG7107-RE, transcript variant E (up), mRNA |
0 |
0 |
4 |
18 |
62 |
NM_134512.4 |
CG12701-RA, transcript variant A (CG12701), mRNA |
0 |
0 |
4 |
18 |
62 |
NM_167685.1 |
CG12701-RB, transcript variant B (CG12701), mRNA |
0 |
0 |
4 |
14 |
83 |
NM_080025.1 |
CG11387-RA, transcript variant A (ct), mRNA |
0 |
0 |
4 |
13 |
70 |
NM_167130.1 |
CG11387-RB, transcript variant B (ct), mRNA |
|